Cargando…
Risks and benefits of TIPS in HCC and other liver malignancies: a literature review
BACKGROUND: Transjugular intrahepatic portosystemic shunt (TIPS) is a well-validated treatment option for clinically significant portal hypertension (CSPH) in the context of liver cirrhosis. Its high efficacy and safety in the management of treatment-refractory ascites and variceal bleeding have bee...
Autores principales: | Fichtl, Anna, Seufferlein, Thomas, Zizer, Eugen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662760/ https://www.ncbi.nlm.nih.gov/pubmed/37986043 http://dx.doi.org/10.1186/s12876-023-03047-0 |
Ejemplares similares
-
Spleen and Liver Stiffness Evaluation by ARFI Imaging: A Reliable Tool for a Short-Term Monitoring of Portal Hypertension?
por: Binzberger, Andreas, et al.
Publicado: (2022) -
Ablative Therapy in Non-HCC Liver Malignancy
por: Robinson, Tyler P., et al.
Publicado: (2023) -
Clinical Significance of Nectins in HCC and Other Solid Malignant Tumors: Implications for Prognosis and New Treatment Opportunities—A Systematic Review
por: Klekowski, Jakub, et al.
Publicado: (2023) -
TIPS Is Not Associated with a Higher Risk of Developing HCC in Cirrhotic Patients: A Systematic Review and Meta-analysis
por: Chen, Bin, et al.
Publicado: (2019) -
Diabetes medications and risk of HCC
por: Plaz Torres, Maria Corina, et al.
Publicado: (2022)